SEC Form 4 · accession 0001354488-17-000311
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Taunia Markvicka
Director
Period of report
Feb 21, 2017
Accepted (ET)
Feb 23, 2017 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 22,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $2.24 | Feb 21, 2017 | A | 40,000 | A | — | Feb 21, 2027 | Common Stock | 40,000 | 40,000 | D |
| Restricted Stock UnitsF2 | — | Feb 21, 2017 | A | 13,571 | A | — | — | Common Stock | 13,571 | 13,571 | D |
| Stock Option (Right to Buyh Common Stock)F3 | $2.05 | holding | — | — | — | — | Apr 3, 2024 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (Right to Buy Common Stock)F1 | $5.62 | holding | — | — | — | — | Mar 1, 2025 | Common Stock | 50,000 | 50,000 | D |
| Stock Option (Right to Buy Common Stock)F1 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F2Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F3These shares vest 1/3 on date of grant, 1/3 on first anniversary of date of grant and 1/3 on second anniversary of date of grant.